TIZONA

Tizona Therapeutics, Inc.

Application Filed: 2018-12-26
Trademark Application Details
Trademark Logo TIZONA

Mark For: TIZONA® trademark registration is intended to cover the categories of pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations and compounds for modulation of the immune system and the tumor microenvironment. [all]

Status

2021-01-09 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88241606
Registration Number6335584
Mark Literal ElementsTIZONA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationTMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED 2020-09-30
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseYes
Current UseYes
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameSharon R Smith
Attorney Docket Number116891-2030

Timeline

2016-05-16Date of First Use
2018-12-26Application Filed
2018-12-29Location: NEW APPLICATION PROCESSING
2018-12-29Status: Live/Pending
2019-01-04Transaction Date
2019-03-11Date of Use In Commerce
2019-04-30Published
2019-04-30Published for Opposition
2020-09-30Location: TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
2020-09-30Status: A final Office action has been sent (issued) to the applicant after review of the Statement of Use. To view all documents in thi
2021-04-27Trademark Registered

Trademark Parties (Applicants & Owners)

Party: TIZONA THERAPEUTICS, INC.
Address4000 Shoreline Court, Suite 200 South San Francisco, CALIFORNIA UNITED STATES 94080
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingJPEG2018-12-26
SpecimenJPEG2018-12-26
TEAS RF New ApplicationMULTI2018-12-26
Notation to FileXML2019-03-19
XSearch Search SummaryXML2019-03-19
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2019-03-20
Notice of PublicationXML2019-04-10
Notification Of Notice of PublicationXML2019-04-10
OG Publication ConfirmationAPPLICATION/XML2019-04-30
Notice of AllowanceXML2019-06-25
Extension of Time to File SOUXML2019-12-20
ITU Extension ApprovalXML2019-12-24
ITU Unit ActionMULTI2019-12-24
SpecimenJPEG2020-06-23
Statement of UseMULTI2020-06-23
ITU Unit ActionMULTI2020-07-14
Offc Action OutgoingXML2020-08-04
Response to Office ActionMULTI2020-09-09
Amendment and Mail Process CompleteMULTI2020-09-10
Offc Action OutgoingXML2020-09-30

Attorney of Record

SHARON R SMITH
MORGAN, LEWIS & BOCKIUS LLP
ONE MARKET ST., SPEAR STREET TOWER
SAN FRANCISCO, CA 94105

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations and compounds for modulation of the immune system and the tumor microenvironment. FIRST USE: 20160516. FIRST USE IN COMMERCE: 20190311
IC 042. US 100 101. G & S: research and development of pharmaceuticals and compounds for the treatment of cancer and autoimmune diseases; research and development of pharmaceuticals and compounds for modulation of the immune system and the tumor microenvironment. FIRST USE: 20160516. FIRST USE IN COMMERCE: 20160516

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0421research and development of pharmaceuticals and compounds for the treatment of cancer and autoimmune diseases; research and development of pharmaceuticals and compounds for modulation of the immune system and the tumor microenvironment
GS0051pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations and compounds for modulation of the immune system and the tumor microenvironment

Trademark Filing History

DescriptionDateProceeding Number
SU - FINAL REFUSAL - WRITTEN2020-09-3082100
NOTIFICATION OF FINAL REFUSAL EMAILED2020-09-30
FINAL REFUSAL E-MAILED2020-09-30
TEAS/EMAIL CORRESPONDENCE ENTERED2020-09-0988889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-09-09
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-09-0988889
SU - NON-FINAL ACTION - WRITTEN2020-08-0482100
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-08-04
NON-FINAL ACTION E-MAILED2020-08-04
STATEMENT OF USE PROCESSING COMPLETE2020-07-1271034
CASE ASSIGNED TO INTENT TO USE PARALEGAL2020-07-1271034
USE AMENDMENT FILED2020-06-2371034
TEAS STATEMENT OF USE RECEIVED2020-06-23
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-12-24
TEAS EXTENSION RECEIVED2019-12-20
EXTENSION 1 GRANTED2019-12-2098765
EXTENSION 1 FILED2019-12-2098765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-06-25
PUBLISHED FOR OPPOSITION2019-04-30
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-04-30
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-04-10
ASSIGNED TO EXAMINER2019-03-1982100
APPROVED FOR PUB - PRINCIPAL REGISTER2019-03-19
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-01-16
NEW APPLICATION ENTERED IN TRAM2018-12-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed